PMID- 34809776
OWN - NLM
STAT- MEDLINE
DCOM- 20211124
LR  - 20221221
IS  - 1879-1131 (Electronic)
IS  - 0738-081X (Print)
IS  - 0738-081X (Linking)
VI  - 39
IP  - 4
DP  - 2021 Jul-Aug
TI  - COVID-19 and Dermatology in Iran.
PG  - 703-706
LID - S0738-081X(21)00087-0 [pii]
LID - 10.1016/j.clindermatol.2021.05.022 [doi]
AB  - COVID-19 infection may affect the individuals with many underlying conditions 
      including skin diseases. This cross-sectional study was conducted to provide an 
      overview regarding the prevalence of COVID-19 disease in the patients with 
      several skin diseases. Overall, 703 patients with several skin diseases 
      participated in the study and completed our online-designed questionnaire. Among 
      the total participants, only 32(4.6%) subjects reported the COVID-19 infection. 
      The prevalence rate was equal to 0.04%. In the patients with psoriasis, 14 out of 
      322 people (4.3%) developed the COVID-19. Three out of 159 patients (1.9%) with 
      alopecia areata had been affected with the COVID-19 and 4 (5.2%) patients with 
      vitiligo had caught the disease. Only one subject (2%) with the lichen planus, 
      and 6 (6.8%) patients with other skin diseases had developed the COVID-19 but in 
      the patients with GVHD (Graft Versus Host Disease), 4 (80%) out of 5 patients had 
      caught the COVID-19 disease. The frequency of COVID-19 infection was low in the 
      studied population however; more studies with larger sample size are needed to 
      determine the exact prevalence of the infection in the patients with skin 
      diseases undergoing the treatment with several systemic medications.
CI  - Copyright (c) 2021 Elsevier Inc. All rights reserved.
FAU - Mansouri, Parvin
AU  - Mansouri P
AD  - Skin and Stem Cell Research Center, Tehran University of Medical Sciences, 
      Tehran, Iran.
FAU - Farshi, Susan
AU  - Farshi S
AD  - Skin and Stem Cell Research Center, Tehran University of Medical Sciences, 
      Tehran, Iran. Electronic address: farshi_s@yahoo.com.
FAU - Nikkhah, Nahid
AU  - Nikkhah N
AD  - Skin and Stem Cell Research Center, Tehran University of Medical Sciences, 
      Tehran, Iran.
FAU - Nobari, Niloufar Najar
AU  - Nobari NN
AD  - Iran University of Medical Sciences, Tehran, Iran.
FAU - Chalangari, Reza
AU  - Chalangari R
AD  - Skin and Stem Cell Research Center, Tehran University of Medical Sciences, 
      Tehran, Iran.
FAU - Nilforoushzadeh, Mohammad Ali
AU  - Nilforoushzadeh MA
AD  - Skin and Stem Cell Research Center, Tehran University of Medical Sciences, 
      Tehran, Iran.
LA  - eng
PT  - Journal Article
DEP - 20210518
PL  - United States
TA  - Clin Dermatol
JT  - Clinics in dermatology
JID - 8406412
SB  - IM
MH  - *COVID-19
MH  - Cross-Sectional Studies
MH  - *Dermatology
MH  - Humans
MH  - Iran/epidemiology
MH  - SARS-CoV-2
MH  - *Vitiligo/epidemiology
PMC - PMC8129800
EDAT- 2021/11/24 06:00
MHDA- 2021/11/25 06:00
PMCR- 2021/05/18
CRDT- 2021/11/23 05:41
PHST- 2021/11/23 05:41 [entrez]
PHST- 2021/11/24 06:00 [pubmed]
PHST- 2021/11/25 06:00 [medline]
PHST- 2021/05/18 00:00 [pmc-release]
AID - S0738-081X(21)00087-0 [pii]
AID - 10.1016/j.clindermatol.2021.05.022 [doi]
PST - ppublish
SO  - Clin Dermatol. 2021 Jul-Aug;39(4):703-706. doi: 
      10.1016/j.clindermatol.2021.05.022. Epub 2021 May 18.